{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-107747","form_type":"8-K","ticker":"QNRX","cik":"0001671502","company_name":"Quoin Pharmaceuticals, Ltd.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.104873+00:00","generated_at":"2026-05-16T23:46:36.639985+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Quoin Pharma reports Q3 net loss of $3.9M, raises up to $105.3M in private placement","bullets":["Net loss of $3.9M for Q3 2025 ($11.5M YTD) vs $2.3M and $6.7M in prior-year periods; R&D spend increased to $2.3M for Q3.","Cash, equivalents, and marketable securities totaled $5.4M as of Sept 30; Oct 2025 added $16.6M upfront from private placement, extending runway into 2027.","Private placement financing closed Oct 2025 with potential gross proceeds up to $105.3M including warrants exercise.","Sally Lawlor appointed CFO; FDA granted Orphan Drug Designation for QRX003 for Netherton Syndrome; pivotal studies to start Q4 2025.","NETHERTON NOW campaign surpassed 1.5M video views since Feb 2025; positive Peeling Skin Syndrome data released."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-107747","json":"https://secwatch.observer/filing/0001104659-25-107747.json","markdown":"https://secwatch.observer/filing/0001104659-25-107747.md","text":"https://secwatch.observer/filing/0001104659-25-107747.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925107747/0001104659-25-107747-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925107747/tm2530187d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:46:36.639985+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}